Key Points

• The standardized national participation rate for the target population was 55.8%, up from 2017 (51.2%) and rising sharply since 2022 (52.3%), but still below the acceptable European threshold of 70%.

• Turnout is rising across all age groups, with a particularly marked increase since 2022 among women aged 45 to 54 (an increase of more than 4 percentage points).

• Significant regional disparities remain. A gap of more than 20 percentage points separates the departments with the highest participation rates (>65%: Morbihan, Finistère, Isère, Hautes-Alpes) and those with the lowest rates (≤45%: Martinique, Seine-Saint-Denis, or even below 27%: French Guiana and Mayotte).

• 13.1% of screenings were conducted through invitation-based screening in 2023, compared to 11.2% in 2021 and 3.3% in 2020.

• Among women aged 30 to 65, the uptake of the HPV test continues to rise: 89.6% of screenings in this age group were performed using this test (versus 30.7% in 2020).

• Screening at a frequency higher than recommended (over-screening) accounts for 16.6% of women screened between the ages of 30 and 65.